← Back to all trials
Recruiting
NCT05617105
Molecular Characterization of Perivascular Epithelioid Cell Tumors
Conditions: Perivascular Epithelioid Cell Tumor, Malignant
Sex: All
Ages: 1 Year – N/A
Enrollment: 100
Sponsor: University Hospital, Strasbourg, France
Location: France
Summary
Perivascular epithelioid cell tumors (PEComas) are rare and are characterized by the expression of myomelanocytic markers.
They are a complex family that includes angiomyolipomas, lymphangioleiomyomatoses and other soft tissue and visceral tumors.
Due to the low prevalence of these tumors, the natural history is unclear; furthermore, a molecular classification integrating clinical, pathological and molecular parameters has not been described to date.
Eligibility Criteria
Inclusion criteria:Major patient (≥18 years)Minor patient (1 to 17 years old)PEComas diagnosed in France between 01/01/1990 and 15/09/2019 and reviewed by a sarcoma referral pathologistExclusion criteria :Opposition of the patient (or the holders of parental authority) to participate in the studyBiological tissue from a patient who does not meet all the inclusion criteriaClassic triphasic angiomyolipoma or lymphangioleiomyomatosisInability to provide informed information to the subjectPatient under court protectionPatient under guardianship or curatorship
Source: ClinicalTrials.gov (NCT05617105). StuddyBuddy aggregates publicly available trial information.